-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Equity healthcare
Overview ( as on 27/06/25 )
NAV
₹39.13
Last change
₹0.1 +0.0%
Fund Size (AUM)
5507.52 Cr
Performance
24.31% (5Y)
Fund Details
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
as of 27/06/25
AUM
5507.52 Cr
Expense Ratio
1.9 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth | 22.63% | 29.45% | 24.31% |
| BSE Healthcare TR INR | 22.11% | 23.78% | 22.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.66% |
Dr Reddy's Laboratories Ltd |
9.66% |
Divi's Laboratories Ltd |
9.03% |
Cipla Ltd |
7.85% |
Aurobindo Pharma Ltd |
6.34% |
Alkem Laboratories Ltd |
4.12% |
Zydus Lifesciences Ltd |
4.01% |
Lupin Ltd |
3.98% |
Gland Pharma Ltd |
3.95% |
Syngene International Ltd |
2.46% |
Sector Allocation
Healthcare |
94.88% |
Basic Materials |
3.81% |
Financial |
1.31% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
24.31% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
23.83% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
23.83% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
21.57% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
21.65% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
21.65% (5Y)
-
